Enhanced efficacy of clindamycin hydrochloride encapsulated in PLA/PLGA based nanoparticle system for oral delivery

Enhanced efficacy of clindamycin hydrochloride encapsulated in PLA/PLGA based nanoparticle system for oral delivery

For access to this article, please select a purchase option:

Buy article PDF
(plus tax if applicable)
Buy Knowledge Pack
10 articles for $120.00
(plus taxes if applicable)

IET members benefit from discounts to all IET publications and free access to E&T Magazine. If you are an IET member, log in to your account and the discounts will automatically be applied.

Learn more about IET membership 

Recommend Title Publication to library

You must fill out fields marked with: *

Librarian details
Your details
Why are you recommending this title?
Select reason:
IET Nanobiotechnology — Recommend this title to your library

Thank you

Your recommendation has been sent to your librarian.

Clindamycin hydrochloride (CLH) is a clinically important oral antibiotic with wide spectrum of antimicrobial activity that includes gram-positive aerobes (staphylococci, streptococci etc.), most anaerobic bacteria, Chlamydia and certain protozoa. The current study was focused to develop a stabilised clindamycin encapsulated poly lactic acid (PLA)/poly (D,L-lactide-co-glycolide) (PLGA) nano-formulation with better drug bioavailability at molecular level. Various nanoparticle (NPs) formulations of PLA and PLGA loaded with CLH were prepared by solvent evaporation method varying drug: polymer concentration (1:20, 1:10 and 1:5) and characterised (size, encapsulation efficiency, drug loading, scanning electron microscope, differential scanning calorimetry [DSC] and Fourier transform infrared [FTIR] studies). The ratio 1:10 was found to be optimal for a monodispersed and stable nano formulation for both the polymers. NP formulations demonstrated a significant controlled release profile extended up to 144 h (both CLH-PLA and CLH-PLGA). The thermal behaviour (DSC) studies confirmed the molecular dispersion of the drug within the system. The FTIR studies revealed the intactness as well as unaltered structure of drug. The CLH-PLA NPs showed enhanced antimicrobial activity against two pathogenic bacteria Streptococcus faecalis and Bacillus cereus. The results notably suggest that encapsulation of CLH into PLA/PLGA significantly increases the bioavailability of the drug and due to this enhanced drug activity; it can be widely applied for number of therapies.


    1. 1)
    2. 2)
    3. 3)
    4. 4)
    5. 5)
    6. 6)
      • 6. Coyle, E.A.: ‘Targeting bacterial virulence: the role of protein synthesis inhibitors in severe infections’, Soc. Infect. Dis. Pharm. Pharmacother., 2003, 23, (5), pp. 638642.
    7. 7)
    8. 8)
    9. 9)
    10. 10)
    11. 11)
    12. 12)
    13. 13)
      • 13. Abdelghany, S.M., Quinn, D.J., Ingram, R.J., et al: ‘Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection’, Int. J. Nanomed., 2012, 7, pp. 40534063.
    14. 14)
    15. 15)
      • 15. Machado, S.R.P., Evangelista, R.C.: ‘Development and characterization of cefoxitin loaded D, L-PLA nanoparticles’, J. Basic. Appl. Sci., 2010, 31, (3), pp. 193202.
    16. 16)
    17. 17)
      • 17. CLSI, Wayne: ‘Clinical and laboratory standards institute methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobicall’, Approve Standard M7-A7, CLSI, seventh ed., PA, USA, 2006.
    18. 18)
    19. 19)
    20. 20)
      • 20. Santhi, K., Venkatesh, D.N., Dhanaraj, S.A., et al: ‘Development and In-vitro evaluation of a topical drug delivery system containing Betamethazone loaded ethyl cellulose nanospheres’, Trop. J. Pharm. Res., 2005, 4, (20), pp. 495500.
    21. 21)
    22. 22)
    23. 23)
      • 23. McNaught, A.D., Wilkinson, A.: Blackwell Scientific Publications, Oxford. Complied version of Nic, M., Jirat, J., Kosata, B. and Jenkins, A. Definition of electro kinetic potential in ‘IUPAC. Compendium of Chemical Terminology’, 2nd ed. (the ‘Gold Book’). XML on-line corrected version: available at (2006-) ISBN0-9678550-9-8, 1997.
    24. 24)
      • 24. Tripathi, A., Gupta, R., Saraf, S.A.: ‘PLGA nanoparticles of anti tubercular drug: drug loading and release studies of a water in-soluble drug’, Int. J. Pharm. Tech. Res., 2010, 2, (3), pp. 21162123.
    25. 25)
    26. 26)
    27. 27)
      • 27. Yasemin, C., Robineau, C., Çapan, Y.: ‘Etodolac loaded Poly (Lactide Co-Glycolide) nanoparticles: formulation and in vitro characterization’, Hacettepe Univ. J Faculty Pharm., 2009, 29, (2), pp. 105114.
    28. 28)
      • 28. Kashi, T.S., Eskandarion, S., Esfandyari-Manesh, M., et al: ‘Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method’, Int. J. Nanomedicine., 2012, 7, pp. 221234.
    29. 29)
    30. 30)
    31. 31)
      • 31. Ford, J.L., Timmins, P.: ‘Pharmaceutical thermal analysis’ (John Wiley & Sons, Chichester, 1989).
    32. 32)
    33. 33)
    34. 34)
    35. 35)
      • 35. Devi, T.S.R., Gayathri, S.: ‘FTIR and FT-Raman spectral analysis of Paclitaxel drugs’, Int. J. Pharmaceut. Sci. Rev. Res., 2010, 2, (2), pp. 106110.
    36. 36)
      • 36. Azhdarzadeh, M., Lotfipour, F., Zakeri-Milani, P., et al: ‘Anti-bacterial performance of azithromycin nanoparticles as colloidal drug delivery system against different gram-negative and gram positive bacteria’, Adv. Pharmaceut. Bull., 2012, 2, (1), pp. 1724.

Related content

This is a required field
Please enter a valid email address